Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Debbarma
Observed name:
Debbarma, Maria
Institution:
Tripura University
Observed institution:
Tripura University
ORCID:
0009-0005-3226-9092
Observed ORCID:
0009-0005-3226-9092
OpenAlex ID:
A5106834128
Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review
2024
·
Maria Debbarma
, Kakali Sarkar
, et al.
·
Medical Oncology
·
8
In silico identification of dual HDAC8 and MMP9 inhibitors by pharmacophore modeling, molecular docking, and molecular dynamics simulation studies for development of antitumour agent
2024
·
Kakali Sarkar
, Maria Debbarma
, et al.
·
Interactions
·
4
Hispidulin and nepetin as promising phytochemical inhibitors of HPV E6: Insights from in silico analysis
2026
·
Maria Debbarma
, Kakali Sarkar
, et al.
·
In Silico Research in Biomedicine
Identification of novel promising HDAC2 inhibitors beyond hydroxamates: A rational pharmacophore-driven computer aided drug design study
2026
·
Kakali Sarkar
, Maria Debbarma
, et al.
·
In Silico Research in Biomedicine
Epigenetic Therapeutic Potential of Dulcitol, a Sugar Alcohol, as a Multi-Target HDAC Inhibitor against cervical cancer: Insights from In Silico Investigations
2025
·
Sarkar, Kakali
, Debbarma, Maria
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Unfolding the role of HDAC2 in the epigenetic puzzle of cancer: A dive into molecular pathways for precision-driven multi-target therapy
2025
·
Kakali Sarkar
, Maria Debbarma
, et al.
·
Biochemical Pharmacology
Show more works
View as search
Works count:
6
Citation count:
12
H-index:
2
I10-index:
Year
Topic
Type
